EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, PTCT:

05 Sep 2025
LAST:

57.26

CHANGE:
 0.75		OPEN:
58.61		HIGH:
58.73		ASK:
15.45		VOLUME:
1.52M
CHG(%):
1.29		PREV:
58.01		LOW:
57.08		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Sep 2558.6158.7357.0857.261.52M
04 Sep 2555.6558.0555.1458.011.9M
03 Sep 2552.8855.7252.4355.551.76M
02 Sep 2549.4753.0649.3852.431.78M
29 Aug 2549.8250.5348.9649.33906.9K
28 Aug 2549.9750.5949.6549.79650.6K
27 Aug 2549.3550.7048.8649.78768.9K
26 Aug 2549.4049.6748.2849.46784.5K
25 Aug 2550.6451.0449.2049.30852.5K
22 Aug 2549.4251.0048.9750.571.05M

COMPANY PROFILE

Name:
About:PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and inflammation and ferroptosis platforms, including vatiquinone to treat Friedreich's ataxia. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. The company has license and collaboration agreement with Novartis Pharmaceuticals Corporation to develop PTC518 Huntington's disease program. It markets Upstaza, a gene therapy with the brand name Kebilidi in the United States. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in Warren, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:500 Warren Corporate Center Drive, Warren, NJ, United States, 07059
Website:https://www.ptcbio.com
CUSIP:69366J200
CIK:0001070081
ISIN:US69366J2006
FIGI:BBG000QT15P7
LEI:549300UJLWOIWFDGB318

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:7.03
Price to Book:1,743.27
Price to Sales:2.23
EBITDA:894.86M
Shares:79.44M
Market Cap:4.549B

TECHNICAL INDICATORS

MA5:54.52
MA10:52.15
MA20:49.91
MA50:49.27
MA100:48.69
MA200:48.45
STO9:84.41
STO14:85.12
RSI14:77.58
WPR14:-8.19
MTM14:7.46
ROC14:0.15
ATR:2.24
Week High:58.73
Week Low:48.96
Month High:58.73
Month Low:43.18
Year High:58.73
Year Low:30.41
Volatility:29.86